Application of mode-of-action considerations in human cancer risk assessment
2008; Elsevier BV; Volume: 180; Issue: 2 Linguagem: Inglês
10.1016/j.toxlet.2008.05.021
ISSN1879-3169
Autores Tópico(s)Effects and risks of endocrine disrupting chemicals
ResumoThe distinction between carcinogens with DNA-reactive and epigenetic modes of action and the application of mode-of-action considerations to risk assessment is reviewed. A bioindicator-based risk assessment strategy is described. This approach involves the use of mechanistic data to establish a "toxicologically insignificant daily intake".
Referência(s)